Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


22.11.2021

3 Am Heart J
13 Am J Cardiol
2 Am J Emerg Med
2 Angiology
2 Ann Thorac Surg
1 Br J Haematol
1 Can J Cardiol
1 Cardiovasc Res
3 Catheter Cardiovasc Interv
1 Circ Cardiovasc Imaging
2 Circ Cardiovasc Qual Outcomes
3 Circ Heart Fail
1 Circ J
4 Circulation
1 Clin Cardiol
2 Crit Care Med
3 Eur Heart J
2 Int J Cardiol
10 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
2 J Clin Invest
1 JAMA
5 Lancet
2 Mol Cell Biochem
2 N Engl J Med
9 PLoS One
1 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. VALLABHAJOSYULA S, Bhopalwala HM, Sundaragiri PR, Dewaswala N, et al
    Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study.
    Am Heart J. 2021 Nov 11. pii: S0002-8703(21)00445.
    PubMed         Abstract available

  2. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed         Abstract available

  3. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    PubMed         Abstract available


    Am J Cardiol

  4. NAVANI RV, Quine EJ, Duffy SJ, Htun NM, et al
    Relation of Preprocedure Platelet-to-Lymphocyte Ratio and Major Adverse Cardiovascular Events Following Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Am J Cardiol. 2021 Nov 11. pii: S0002-9149(21)01002.
    PubMed         Abstract available

  5. RODENAS-ALESINA E, Cabeza-Martinez P, Zamora-Putin V, Pariggiano I, et al
    Long-Term Variation in Kidney Function and Its Impact After Acute Myocardial Infarction.
    Am J Cardiol. 2021 Nov 8. pii: S0002-9149(21)00997.
    PubMed         Abstract available

  6. ZAHLER D, Rozenfeld KL, Pasternak Y, Itach T, et al
    Relation of Pain-to-Balloon Time and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Am J Cardiol. 2021 Nov 8. pii: S0002-9149(21)00999.
    PubMed         Abstract available

  7. MURUGIAH K, Chen L, Castro-Dominguez Y, Khera R, et al
    Scope of Practice of US Interventional Cardiologists from an Analysis of Medicare Billing Data.
    Am J Cardiol. 2021;160:40-45.
    PubMed         Abstract available

  8. CASE BC, Abramowitz J, Shea C, Rappaport H, et al
    Comparison of Outcomes in Patients With COVID-19 and Thrombosis Versus Those Without Thrombosis.
    Am J Cardiol. 2021;160:106-111.
    PubMed         Abstract available

  9. LAK HM, Chawla S, Gajulapalli RD, Verma BR, et al
    Outcomes After Transfemoral Transcatheter Aortic Valve Implantation With a SAPIEN 3 Valve in Patients With Cirrhosis of the Liver (a Tertiary Care Center Experience).
    Am J Cardiol. 2021 Sep 25. pii: S0002-9149(21)00829.
    PubMed         Abstract available

  10. HEUTS S, Denessen EJS, Daemen JHT, Vroemen WHM, et al
    Meta-Analysis Evaluating High-Sensitivity Cardiac Troponin T Kinetics after Coronary Artery Bypass Grafting in Relation to the Current Definitions of Myocardial Infarction.
    Am J Cardiol. 2021 Nov 8. pii: S0002-9149(21)00998.
    PubMed         Abstract available

  11. MCNAMARA DA, Bennett AJ, Ayers C, Berry JD, et al
    Relations Between Cardiac Magnetic Resonance Imaging-Derived Left Ventricular Mass, Early Repolarization, and Cardiovascular Events (from the Dallas Heart Study).
    Am J Cardiol. 2021;161:108-114.
    PubMed         Abstract available

  12. MARAEY A, Elzanaty AM, Salem M, Khalil M, et al
    Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Am J Cardiol. 2021;161:56-62.
    PubMed         Abstract available

  13. DEMIDOVA MM, Ulfarsson AEO, Carlson J, Erlinge D, et al
    Relation of Early Monomorphic Ventricular Tachycardia to Long-Term Mortality in ST-Elevation Myocardial Infarction.
    Am J Cardiol. 2021 Nov 10. pii: S0002-9149(21)00989.
    PubMed         Abstract available

  14. ROBERTS WC, Khan OS
    The Syndrome of Large Healed Single Discrete Myocardial Infarct with Severe Narrowing of Only One Major Epicardial Coronary Artery and Leading to Severe Chronic Heart Failure and Orthotopic Heart Transplantation.
    Am J Cardiol. 2021;161:1-11.
    PubMed         Abstract available

  15. SAKAGUCHI Y, Sato T, Sato A, Fuse K, et al
    Incidence and Implications of J waves Observed During Coronary Angiography.
    Am J Cardiol. 2021 Nov 10. pii: S0002-9149(21)00990.
    PubMed         Abstract available

  16. BOUDREAU R, Fu AYN, Barry QS, Clifford CR, et al
    Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions.
    Am J Cardiol. 2021;161:19-25.
    PubMed         Abstract available


    Am J Emerg Med

  17. PATLOLLA SH, Shankar A, Sundaragiri PR, Cheungpasitporn W, et al
    Racial and ethnic disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction.
    Am J Emerg Med. 2021;51:202-209.
    PubMed         Abstract available

  18. GOLDENBERG M, Kharsa A, Farooq S, Bisognano JD, et al
    Outcomes associated with the high sensitivity cardiac troponin testing in patients presenting with non-cardiovascular disorders.
    Am J Emerg Med. 2021;51:280-284.
    PubMed         Abstract available


    Angiology

  19. DAI C, Yao Z, Chen Z, Qian J, et al
    A Simple Model to Predict Repeat Revascularization After Drug-Eluting Stent Implantation in Patients With Stable Coronary Artery Disease.
    Angiology. 2021 Nov 18:33197211052133. doi: 10.1177/00033197211052133.
    PubMed         Abstract available

  20. PSARAKIS G, Farmakis I, Zafeiropoulos S, Kourti O, et al
    Predictive Role of Platelet-Associated Indices on Admission and Discharge in the Long-Term Prognosis of Acute Coronary Syndrome Patients.
    Angiology. 2021 Nov 14:33197211052134. doi: 10.1177/00033197211052134.
    PubMed         Abstract available


    Ann Thorac Surg

  21. QU WW, Wei JW, Binongo JN, Keeling WB, et al
    Gender Differences in Failure-to-Rescue After Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2021 Nov 11. pii: S0003-4975(21)01888.
    PubMed         Abstract available

  22. HANNAN EL, Wu Y, Cozzens K, Friedrich M, et al
    The Association of Socio-Economic Factors with Outcomes for Coronary Artery Bypass Surgery.
    Ann Thorac Surg. 2021 Nov 11. pii: S0003-4975(21)01886.
    PubMed         Abstract available


    Br J Haematol

  23. CHEN S, Chen D, Liu Y, Xu Y, et al
    Enhanced clot lysis by a single point mutation in a reteplase variant.
    Br J Haematol. 2021 Nov 16. doi: 10.1111/bjh.17942.
    PubMed         Abstract available


    Can J Cardiol

  24. XIE Y, Seidman MA
    Inflammatory Comments in Coronary Artery Disease: When to Suspect Polyarteritis Nodosa or Other Primary Systemic Vasculitis.
    Can J Cardiol. 2021;37:830-832.
    PubMed        


    Cardiovasc Res

  25. NOSALSKI R, Guzik TJ
    IL-15 and IL-7: keys to dysregulated inflammation in acute coronary syndromes.
    Cardiovasc Res. 2021;117:1806-1808.
    PubMed        


    Catheter Cardiovasc Interv

  26. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    PubMed         Abstract available

  27. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed        

  28. SCARSINI R, Fezzi S, Pesarini G, Del Sole PA, et al
    Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy.
    Catheter Cardiovasc Interv. 2021 Nov 10. doi: 10.1002/ccd.30007.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  29. FREANEY PM, Petito L, Colangelo LA, Lewis CE, et al
    Association of Premature Menopause With Coronary Artery Calcium: The CARDIA Study.
    Circ Cardiovasc Imaging. 2021;14:e012959.
    PubMed        


    Circ Cardiovasc Qual Outcomes

  30. PASUPATHY S, Lindahl B, Litwin P, Tavella R, et al
    Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration.
    Circ Cardiovasc Qual Outcomes. 2021;14:e007880.
    PubMed         Abstract available

  31. FERRO EG, Abrahams-Gessel S, Jardim TV, Wagner R, et al
    Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa.
    Circ Cardiovasc Qual Outcomes. 2021;14:e007847.
    PubMed         Abstract available


    Circ Heart Fail

  32. YANG JH, Choi KH, Ko YG, Ahn CM, et al
    Clinical Characteristics and Predictors of In-Hospital Mortality in Patients With Cardiogenic Shock: Results From the RESCUE Registry.
    Circ Heart Fail. 2021;14:e008141.
    PubMed         Abstract available

  33. HERNANDEZ-MONTFORT J, Sinha SS, Thayer KL, Whitehead EH, et al
    Clinical Outcomes Associated with Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock.
    Circ Heart Fail. 2021 Apr 27. doi: 10.1161/CIRCHEARTFAILURE.120.007924.
    PubMed         Abstract available

  34. VARSHNEY AS, Omar WA, Goodrich EL, Bhatt AS, et al
    Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19 : A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Circ Heart Fail. 2021 Nov 18:CIRCHEARTFAILURE121008477.
    PubMed        


    Circ J

  35. WANG Z, Yin Y, Li J, Qi W, et al
    New Ultrasound-Controlled Paclitaxel Releasing Balloon vs. Asymmetric Drug-Eluting Stent in Primary ST-Segment Elevation Myocardial Infarction- A Prospective Randomized Trial.
    Circ J. 2021 Nov 10. doi: 10.1253/circj.CJ-21-0315.
    PubMed         Abstract available


    Circulation

  36. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
    Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
    Circulation. 2021;144:1656-1658.
    PubMed        

  37. LAI Y, Zhuang X, Liao X
    Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
    Circulation. 2021;144:e307.
    PubMed        

  38. HAKALA JO, Raitakari OT, Rovio SP
    Response by Hakala et al to Letter Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
    Circulation. 2021;144:e308-e309.
    PubMed        

  39. SREEJIT G, Nooti SK, Jaggers RM, Athmanathan B, et al
    Retention of the NLRP3 Inflammasome-primed Neutrophils in the Bone Marrow is Essential for Myocardial Infarction-induced Granulopoiesis.
    Circulation. 2021 Nov 17. doi: 10.1161/CIRCULATIONAHA.121.056019.
    PubMed         Abstract available


    Clin Cardiol

  40. DISSANAYAKE HU, Colpani JT, Sutherland K, Loke W, et al
    Obstructive sleep apnea therapy for cardiovascular risk reduction-Time for a rethink?
    Clin Cardiol. 2021 Nov 17. doi: 10.1002/clc.23747.
    PubMed         Abstract available


    Crit Care Med

  41. MEUWESE CL, Pladet CLA, Kraaijeveld AO, Donker DW, et al
    Improved Survival Through Early Versus Late Impella Support for Myocardial Infarction-Related Shock? Mind Your Step!
    Crit Care Med. 2021;49:e1276-e1277.
    PubMed        

  42. HIROI S, Imamura T
    Implication of Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Crit Care Med. 2021;49:e1274.
    PubMed        


    Eur Heart J

  43. PITT B, Ferreira JP, Zannad F
    Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
    Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
    PubMed        

  44. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
    Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
    Eur Heart J. 2021;42:4402-4403.
    PubMed        

  45. DERIMAY F, Finet G, Rioufol G
    Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
    Eur Heart J. 2021;42:4401.
    PubMed        


    Int J Cardiol

  46. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    PubMed         Abstract available

  47. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    PubMed        


    J Am Coll Cardiol

  48. GIRI J, Fanaroff AC
    1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: The New Standard?
    J Am Coll Cardiol. 2021;78:2073-2075.
    PubMed        

  49. DAVIDSON BP, Hodovan J, Layoun ME, Golwala H, et al
    Echocardiographic Ischemic Memory Molecular Imaging for Point-of-Care Detection of Myocardial Ischemia.
    J Am Coll Cardiol. 2021;78:1990-2000.
    PubMed         Abstract available

  50. HONDA Y, Mok Y, Ishigami J, Ashley KE, et al
    The Fifth-Generation Cardiac Troponin T and Cardiovascular Disease in the Community.
    J Am Coll Cardiol. 2021;78:2019-2021.
    PubMed        

  51. LIU M, Figueroa JF, Song Y, Wadhera RK, et al
    Mortality and Postdischarge Acute Care Utilization for Cardiovascular Conditions at Safety-Net Versus Non-Safety-Net Hospitals.
    J Am Coll Cardiol. 2021 Oct 26. pii: S0735-1097(21)07800.
    PubMed        

  52. LEITER LA, Bhatt DL, McGuire DK, Teoh H, et al
    Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
    J Am Coll Cardiol. 2021;77:2366-2377.
    PubMed         Abstract available

  53. ANDERSSON C, Nayor M, Tsao CW, Levy D, et al
    Framingham Heart Study: JACC Focus Seminar, 1/8.
    J Am Coll Cardiol. 2021;77:2680-2692.
    PubMed         Abstract available

  54. BROUWERS RWM, Kraal JJ, Regis M, Spee RF, et al
    Effectiveness of Cardiac Telerehabilitation With Relapse Prevention: SmartCare-CAD Randomized Controlled Trial.
    J Am Coll Cardiol. 2021;77:2754-2756.
    PubMed        

  55. BURGESS SN, Juergens CP, Mussap CJ, Lo STH, et al
    Cardiogenic Shock, the Residual SYNTAX Score, and Prognosis: Corroborative "Real-World" Data.
    J Am Coll Cardiol. 2021;77:2871-2872.
    PubMed        

  56. LI X, Ni S
    Could Residual SYNTAX Score Predict the Prognosis of Patients With Cardiogenic Shock?
    J Am Coll Cardiol. 2021;77:2872.
    PubMed        

  57. BARTHELEMY O, Rouanet S, Zeymer U, Thiele H, et al
    Reply: The Residual SYNTAX Score: A Useful Tool to Predict Outcomes in Cardiogenic Shock.
    J Am Coll Cardiol. 2021;77:2872-2873.
    PubMed        


    J Cardiovasc Pharmacol

  58. CATURANO A, Spiezia S, Sasso FC
    Statin effect on Major Adverse Cardiac Events after Percutaneous Coronary Intervention in Patients on Haemodialysis.
    J Cardiovasc Pharmacol. 2021 Nov 3. pii: 00005344-900000000-98118.
    PubMed        


    J Clin Invest

  59. BRAKENHIELM E, Chen Y, Cao Y
    Lymphatics in the broken heart.
    J Clin Invest. 2021;131.
    PubMed         Abstract available

  60. KNUTSON AK, Williams AL, Boisvert WA, Shohet RV, et al
    HIF in the heart: development, metabolism, ischemia, and atherosclerosis.
    J Clin Invest. 2021;131.
    PubMed         Abstract available


    JAMA

  61. AMINIAN A, Al-Kurd A, Wilson R, Bena J, et al
    Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    JAMA. 2021 Nov 11. pii: 2786270. doi: 10.1001/jama.2021.19569.
    PubMed         Abstract available


    Lancet

  62. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    PubMed         Abstract available

  63. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    PubMed        

  64. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed         Abstract available

  65. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed         Abstract available

  66. LONNEBAKKEN MT
    The risk of no risk in STEMI.
    Lancet. 2021;397:1039-1040.
    PubMed        


    Mol Cell Biochem

  67. JU J, Song YN, Chen XZ, Wang T, et al
    circRNA is a potential target for cardiovascular diseases treatment.
    Mol Cell Biochem. 2021 Nov 15. pii: 10.1007/s11010-021-04286.
    PubMed         Abstract available

  68. TANG XL, Wysoczynski M, Gumpert AM, Li Y, et al
    Effect of intravenous cell therapy in rats with old myocardial infarction.
    Mol Cell Biochem. 2021 Nov 16. pii: 10.1007/s11010-021-04283.
    PubMed         Abstract available


    N Engl J Med

  69. MA Y, He FJ, Sun Q, Yuan C, et al
    24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2109794.
    PubMed         Abstract available

  70. VALGIMIGLI M, Frigoli E, Heg D, Tijssen J, et al
    Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
    N Engl J Med. 2021;385:1643-1655.
    PubMed         Abstract available


    PLoS One

  71. NAKAYAMA N, Miyachi M, Tamakoshi K, Hayashi T, et al
    Decreased continuous sitting time increases heart rate variability in patients with cardiovascular risk factors.
    PLoS One. 2021;16:e0253399.
    PubMed         Abstract available

  72. BIBI S, Khan A, Nadeem A, Mushtaq S, et al
    Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents.
    PLoS One. 2021;16:e0253290.
    PubMed         Abstract available

  73. GOUDA P, Savu A, Bainey KR, Kaul P, et al
    Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes.
    PLoS One. 2021;16:e0254008.
    PubMed         Abstract available

  74. VUOTI AO, Tulppo MP, Ukkola OH, Junttila MJ, et al
    Prognostic value of heart rate variability in patients with coronary artery disease in the current treatment era.
    PLoS One. 2021;16:e0254107.
    PubMed         Abstract available

  75. FOKOUA-MAXIME CD, Seukep AJ, Bellouche Y, Cheuffa-Karel TE, et al
    Prevalence of unrecognized or "silent" myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis.
    PLoS One. 2021;16:e0256934.
    PubMed         Abstract available

  76. SATO R, Akita K, Ikoma T, Iguchi K, et al
    Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention.
    PLoS One. 2021;16:e0257227.
    PubMed         Abstract available

  77. MATYAL R, Qureshi NQ, Mufarrih SH, Sharkey A, et al
    Update: Gender differences in CABG outcomes-Have we bridged the gap?
    PLoS One. 2021;16:e0255170.
    PubMed         Abstract available

  78. TAKEJI Y, Shiomi H, Morimoto T, Yamamoto K, et al
    Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction.
    PLoS One. 2021;16:e0259268.
    PubMed         Abstract available

  79. BIGLER MR, Seiler C
    Detection of myocardial ischemia by intracoronary ECG using convolutional neural networks.
    PLoS One. 2021;16:e0253200.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  80. LAVIE CJ, Bernasconi A
    Impressive results with EPA, but EPA/DHA combinations also reduce cardiovascular outcomes.
    Prog Cardiovasc Dis. 2021 Nov 15. pii: S0033-0620(21)00121.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: